| scholarly article | Q13442814 |
| P50 | author | Christian Gluud | Q26265142 |
| Jørn Wetterslev | Q28037207 | ||
| Stig Yndgaard | Q56245500 | ||
| Per Winkel | Q92057883 | ||
| Anne Benedicte Juul | Q114426381 | ||
| Allan Kofoed-Enevoldsen | Q114426382 | ||
| Torben Callesen | Q114426383 | ||
| P2093 | author name string | Jørgen Jørgensen | |
| Dusanka Zaric | |||
| Per Jensen | |||
| Morten Bestle | |||
| Stig Yndgaard | |||
| Jon Jacobsen | |||
| Lise Lotte Nielsen | |||
| Pernille Lykke Petersen | |||
| Peter Nørgaard | |||
| Jørgen Hilden | |||
| Klavs Boysen | |||
| Gorm Jensen | |||
| Gun Johansson | |||
| Jakob Roed | |||
| Frank Pott | |||
| Anne Munksgaard | |||
| Nader Salas | |||
| Lise Jørgensen | |||
| Boris Khanykin | |||
| Lars Peter Wang | |||
| Pia Stjernholm | |||
| André Miran | |||
| Bjarne Øberg | |||
| Bjørn Dehlie | |||
| DIPOM Trial Group | |||
| Grazyna Perko | |||
| Jeanie Elkjaer | |||
| Jørn Bo Madsen | |||
| Kim Fruergaard | |||
| Maj-Britt Mortensen | |||
| Marie-Louise Rovsing | |||
| Merete Haas | |||
| Nikolai Bang Foss | |||
| Rikke Albret | |||
| Rune Vedelsdal | |||
| Tine Blemmer | |||
| Yvonne Mølgaard | |||
| P2860 | cites work | Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses | Q24289247 |
| Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses | Q29619185 | ||
| ACC/AHA guidelines as predictors of postoperative cardiac outcomes | Q33812151 | ||
| Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study | Q34089757 | ||
| Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. | Q34251047 | ||
| Multifactorial index of cardiac risk in noncardiac surgical procedures | Q34417575 | ||
| How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials | Q36183773 | ||
| Long-term postoperative mortality in diabetic patients undergoing major non-cardiac surgery | Q40488550 | ||
| Lack of physician concordance with guidelines on the perioperative use of beta-blockers | Q43493112 | ||
| The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery | Q44839241 | ||
| Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group | Q45989470 | ||
| Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial | Q46473007 | ||
| Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group | Q46581479 | ||
| Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group | Q46651609 | ||
| International criteria for the diagnosis of diabetes and impaired glucose tolerance. | Q53426836 | ||
| The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery | Q56893725 | ||
| A Large Trial Is Vital to Prove Perioperative β-blockade Effectiveness and Safety before Widespread Use | Q59745917 | ||
| Perioperative beta-blocker withdrawal and mortality in vascular surgical patients | Q73341545 | ||
| Equal Efficacy and Improved Tolerability with 50 mg Controlled-Release Metoprolol Compared with 100 mg Conventional Metoprolol in Hypertensive Patients | Q77614194 | ||
| ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 | Q77753978 | ||
| The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade | Q79913869 | ||
| Perioperative beta-blocker therapy and mortality after major noncardiac surgery | Q80947516 | ||
| Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome | Q81272805 | ||
| P433 | issue | 7556 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiac surgery | Q235007 |
| multicenter clinical trial | Q6934595 | ||
| placebo | Q269829 | ||
| P304 | page(s) | 1482 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial | |
| P478 | volume | 332 |
| Q34431980 | 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of A |
| Q42134079 | 3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology. |
| Q34324204 | A randomized feasibility trial of clonidine to reduce perioperative cardiac risk in patients on chronic beta-blockade: the EPIC study. |
| Q34987813 | A regional quality improvement effort to increase beta blocker administration before vascular surgery |
| Q88786608 | Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017 |
| Q49134468 | Back to the future: medical reversals and perioperative medicine |
| Q42741918 | Beta blockers and statins in non-cardiac surgery |
| Q24243256 | Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery |
| Q24186611 | Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery |
| Q38687689 | Beta-blocker subtype and risks of perioperative adverse events following non-cardiac surgery: a nationwide cohort study |
| Q37702033 | Beta-blockers and risk of all-cause mortality in non-cardiac surgery |
| Q57389407 | Beta-blockers for non-acute treatment after myocardial infarction |
| Q57389442 | Beta-blockers for suspected or diagnosed acute myocardial infarction |
| Q38071617 | Cardiac risk assessment before non-cardiac surgery |
| Q36955252 | Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression |
| Q38915553 | Commentary : The value of intraoperative neurophysiological monitoring: evidence, equipoise and outcomes |
| Q33654004 | Coronary Risk Assessment and Management Options in Chronic Kidney Disease Patients Prior to Kidney Transplantation |
| Q97529789 | Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study |
| Q34778589 | Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial |
| Q36633988 | Elevated cardiac troponin in the early post-operative period and mortality following ruptured abdominal aortic aneurysm: a retrospective population-based cohort study |
| Q38012515 | Endovascular aneurysm repair: a perioperative perspective |
| Q42707836 | Essay for the CIHR/CMAJ award: impact of the Perioperative Ischemic Evaluation (POISE) trial |
| Q33710053 | Evidence at a glance: error matrix approach for overviewing available evidence |
| Q35580952 | Genetic variation, β-blockers, and perioperative myocardial infarction |
| Q43284567 | Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery |
| Q57245270 | Guía de práctica clínica para la valoración del riesgo cardiaco preoperatorio y el manejo cardiaco perioperatorio en la cirugía no cardiaca |
| Q40386821 | Impact of Beta-Blocker Initiation Timing on Mortality Risk in Patients With Diabetes Mellitus Undergoing Noncardiac Surgery: A Nationwide Population-Based Cohort Study |
| Q46804046 | Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients |
| Q43799950 | Influence of central venous oxygen saturation on in-hospital mortality of surgical patients |
| Q24289034 | Learning from mistakes in clinical practice guidelines: the case of perioperative β-blockade |
| Q34361033 | Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery |
| Q33378097 | Microvascular flow and tissue oxygenation after major abdominal surgery: association with post-operative complications |
| Q37892419 | Minimizing cardiac risk in perioperative practice - interdisciplinary pharmacological approaches |
| Q64092615 | New advances in perioperative cardioprotection |
| Q38107887 | Patients who require non-cardiac surgery in acute coronary syndrome |
| Q41343181 | Patterns of β-blocker initiation in patients undergoing intermediate to high-risk noncardiac surgery |
| Q38653570 | Peri-operative cardiac protection for non-cardiac surgery |
| Q43680221 | Perioperative beta blockade |
| Q37326885 | Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis |
| Q41733759 | Perioperative beta-blockade: might the baby go out with the bath water? |
| Q24193541 | Perioperative beta-blockers for preventing surgery-related mortality and morbidity |
| Q90297209 | Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery |
| Q51740838 | Perioperative beta-blockers for preventing surgery-related mortality and morbidity. |
| Q42028649 | Perioperative evaluation of cardiac surgical risk: particularities in the emergency surgery - from the guidelines to the clinical practice |
| Q42415622 | Perioperative use of beta-blockers |
| Q37381635 | Preoperative Cardiac Evaluation and Management of the Patient Undergoing Major Vascular Surgery |
| Q37992531 | Preoperative cardiac evaluation of the vascular surgery patient--an anesthesia perspective |
| Q40792445 | Preoperative β-blockers do not improve cardiac outcomes after major elective vascular surgery and may be harmful |
| Q37472056 | Prevention of acute coronary events in noncardiac surgery: beta-blocker therapy and coronary revascularization |
| Q42532701 | Prognostic studies of perioperative risk: robust methodology is needed. |
| Q37784896 | Risk Assessment for Pulmonary Resection |
| Q37830055 | Safety of perioperative β-blocker use: how do β-blockers compare in terms of side effects? |
| Q37800343 | Screening and management of pretransplant cardiovascular disease |
| Q44554341 | The Revised Cardiac Risk Index in the new millennium: a single-centre prospective cohort re-evaluation of the original variables in 9,519 consecutive elective surgical patients |
| Q48216139 | The influence of pre-admission hypoglycaemic therapy on cardiac morbidity and mortality in type 2 diabetic patients undergoing major non-cardiac surgery: a prospective observational study. |
| Q40010548 | Treatment recommendations to prevent myocardial ischemia and infarction in patients undergoing vascular surgery |
| Q24289436 | Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis |
| Q79359221 | Update in perioperative medicine |
| Q59320923 | Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial i |
| Q45963999 | [Beta-blockers in patients undergoing noncardiac surgery: implications of the POISE study]. |
| Q84039945 | [Perioperative beta-receptor blockade. For and against] |
| Q79889653 | [Perioperative cardioprotection. Golden standard beta-blockade?] |
| Q82510855 | [Perioperative management of long-term medication] |
| Q46505424 | [Perioperative pharmacological myocardial protection. Systematic literature-based process optimization]. |
| Q40945236 | β-blockers in critically ill patients: from physiology to clinical evidence. |
Search more.